Neoleukin Therapeutics Inc (NLTX)

Sector:
HEALTH CARE
Industry:
PHARMACEUTICALS
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Dr. Jonathan G. Drachman
Employees:
8
SUITE 360 - 1616 EASTLAKE AVE EAST SEATTLE WA 98102
206-732-2133

Neoleukin Therapeutics, Inc., a biopharmaceutical company, develops immunotherapies for cancer, inflammation, and autoimmunity disorders using protein design technology.

Data derived from most recent annual or quarterly report
Market Cap 288.915 Million Shares Outstanding42.425 Million Avg 30-day Volume 89.557 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS-2.15
Price to Revenue31.4986 Debt to Equity0.0 EBITDA-33.382 Million
Price to Book Value2.6665 Operating Margin-358.9646 Enterprise Value217.946 Million
Current Ratio7.516 EPS Growth0.721 Quick Ratio6.953
1 Yr BETA 52-week High/Low 17.95 / 5.95 Profit Margin-363.205
Operating Cash Flow Growth-45.7097 Altman Z-Score13.1882 Free Cash Flow to Firm -55.319 Million

Are you looking for this stock instead?

View SEC Filings from NLTX instead.

View recent insider trading info

Funds Holding NLTX (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding NLTX BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

DRACHMAN JONATHAN G PRESIDENT AND CEO

  • Officer
  • Director
2,398,686 2021-08-24 3

HO ROBERT CHIEF FINANCIAL OFFICER

  • Officer
190,000 2021-08-03 2

VANCE HOLLY GENERAL COUNSEL

  • Officer
100,000 2021-08-03 1

WALKEY CARL SENIOR VICE PRESIDENT

  • Officer
100,000 2021-08-03 27

PATEL PRITI CHIEF MEDICAL OFFICER

  • Officer
50,000 2021-08-03 3

BAKER BROS. ADVISORS LP

667, L.P.

BAKER BROS. ADVISORS (GP) LLC

BAKER BROTHERS LIFE SCIENCES LP

BAKER FELIX

BAKER JULIAN

  • Director
25,000 2021-05-11 1

SIMPSON TODD E

  • Director
25,000 2021-05-11 1

BABLER MARTIN

  • Director
25,000 2021-05-11 1

WILLIAMS LEWIS T

  • Director
25,000 2021-05-11 1

NOONBERG SARAH B.

  • Director
25,000 2021-05-11 1

LAVELLE ERIN M.

  • Director
25,000 2021-05-11 1

NOLAN SEAN P.

  • Director
0 2020-05-05 0

REDMILE GROUP, LLC

GREEN JEREMY

  • 10% Owner
4,041,211 2020-03-27 0

BOYD META CANTEY

  • Director
0 2019-08-08 0

MAIN DAVID PRESIDENT AND CEO

  • Officer
  • Director
0 2018-08-07 0

ALAM KAMRAN CFO, VICE PRESIDENT FINANCE

  • Officer
0 2018-08-07 0

MACKENZIE LLOYD CHIEF OPERATING OFFICER

  • Officer
0 2018-08-07 0

MCCLOSKEY SHELLEY VP, HR AND ADMINISTRATION

  • Officer
0 2018-08-07 0

LEVITT DANIEL J

  • Director
0 2018-05-14 0

PELZER ROBERT

  • Director
0 2018-05-07 0

BRIDGER GARY

  • Director
0 2018-05-07 0

TROUPIN BARBARA CHIEF MEDICAL OFFICER

  • Officer
0 2018-03-09 0

JENKINS ABIGAIL CHIEF COMMERCIAL OFFICER

  • Officer
0 2018-03-09 0

LEVY RICHARD S

  • Director
0 2017-03-23 0

NEU KELVIN

  • Director
36 2017-03-23 0

MITCHELL DAVID CHILTON VP GLOBAL REGULATORY & QUALITY

  • Officer
0 2017-03-08 0

BAKER BROS. ADVISORS LP

BAKER BROS. ADVISORS (GP) LLC

BAKER FELIX

BAKER JULIAN

  • 10% Owner
10,938,674 2017-01-09 0

SHREWSBURY STEPHEN B CMO; SENIOR VP CLINICAL DEV.

  • Officer
0 2016-03-10 0

PFIZER INC

  • 10% Owner
No longer subject to file 2015-08-10 0

JOHNSON & JOHNSON

JOHNSON & JOHNSON INNOVATION - JJDC, INC.

  • 10% Owner
No longer subject to file 2015-08-10 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
NEOLEUKIN THERAPEUTICS INC NLTX 2021-10-26 17:45:03 UTC -0.2335 0.3035 400000
NEOLEUKIN THERAPEUTICS INC NLTX 2021-10-26 17:15:03 UTC -0.2335 0.3035 400000
NEOLEUKIN THERAPEUTICS INC NLTX 2021-10-26 16:45:04 UTC -0.2466 0.3166 400000
NEOLEUKIN THERAPEUTICS INC NLTX 2021-10-26 16:15:03 UTC -0.2466 0.3166 400000
NEOLEUKIN THERAPEUTICS INC NLTX 2021-10-26 15:45:03 UTC -0.2466 0.3166 400000
NEOLEUKIN THERAPEUTICS INC NLTX 2021-10-26 15:15:03 UTC -0.2466 0.3166 400000
NEOLEUKIN THERAPEUTICS INC NLTX 2021-10-26 14:45:03 UTC -0.255 0.325 400000
NEOLEUKIN THERAPEUTICS INC NLTX 2021-10-26 14:15:05 UTC -0.255 0.325 400000
NEOLEUKIN THERAPEUTICS INC NLTX 2021-10-26 13:45:03 UTC -0.255 0.325 400000
NEOLEUKIN THERAPEUTICS INC NLTX 2021-10-26 13:15:03 UTC -0.255 0.325 400000
NEOLEUKIN THERAPEUTICS INC NLTX 2021-10-26 12:45:03 UTC -0.255 0.325 400000
NEOLEUKIN THERAPEUTICS INC NLTX 2021-10-25 22:15:03 UTC -0.255 0.325 350000
NEOLEUKIN THERAPEUTICS INC NLTX 2021-10-25 21:45:03 UTC -0.255 0.325 350000
NEOLEUKIN THERAPEUTICS INC NLTX 2021-10-25 21:15:03 UTC -0.255 0.325 350000
NEOLEUKIN THERAPEUTICS INC NLTX 2021-10-25 20:45:03 UTC -0.255 0.325 350000
NEOLEUKIN THERAPEUTICS INC NLTX 2021-10-25 20:15:03 UTC -0.255 0.325 350000
NEOLEUKIN THERAPEUTICS INC NLTX 2021-10-25 19:45:04 UTC -0.255 0.325 350000
NEOLEUKIN THERAPEUTICS INC NLTX 2021-10-25 19:15:03 UTC -0.255 0.325 350000
NEOLEUKIN THERAPEUTICS INC NLTX 2021-10-25 18:45:02 UTC -0.255 0.325 350000
NEOLEUKIN THERAPEUTICS INC NLTX 2021-10-25 18:15:03 UTC -0.255 0.325 350000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments